Drawing for Serial No. 79137107

USPTO serial 79137107

Serial No. 79137107

Reviewed by CopyMark Law Group

Reg. 4705701Status 706Registered
Filing date
Status date
Registration date
Mar 24, 2015
Examiner
GLASSER, CARYN
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with Serial No. 79137107?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210-2206United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biological preparations used in industry, science and agriculture, namely, biotechnological and biological substances in the nature of cells, cell lines, nucleic acids, recombinant proteins, antigens, blood sera, antibodies and fragments thereof other than for medical or veterinary use; biotechnological products, namely, diagnostic preparations for research and diagnostic uses; biological viral preparations and biological preparations for use in cell cultures other than for medical or veterinary use; bacterial and viral substances other than for medical and veterinary uses; chemicals and biological chemical preparations for use in medical science, namely, for use in biochemical and clinical research; microorganisms, viruses, viral vectors, [ nucleic acids, ] other than for medical or veterinary purposesACTIVE—
005Pharmaceutical products for human and veterinary uses for treatment of infectious diseases, autoimmune disorders, cancer, immunological diseases; medical preparations, namely, diagnostic preparations for medical use; chemical preparations for pharmaceutical and medical purposes, namely, infectious diseases, autoimmune disorders, cancer, immunological diseases; biotechnological preparations for medical purposes, namely, medical diagnostic reagents; proteins, viral substances, immunological substances, bacterial substances, enzymatic substances, vaccines and biopharmaceutical preparations for use in human and veterinary medicine for treatment of infectious diseases, autoimmune disorders, cancer, immunological diseases; diagnostic preparations for use in human and veterinary medicine; chemical reagents for medical and veterinary purposes; cell cultures, microorganisms and viruses for medical and veterinary use; adjuvants used for medical and veterinary uses; antibiotic substances; vaccines; living cells and microorganisms as well as viral vectors, proteins, peptides and nucleic acids or complexes of these molecules for medical and veterinary purposes; antibodies and fragments thereof for use in disease testing; cells for medical, pharmaceutical and veterinary usesACTIVE—
042Scientific research and pharmaceutical development services; scientific research services in the medical, pharmaceutical and veterinary field; scientific and industrial research in particular in the field of biology, molecular biology, cell biology, biotechnology, bacteriology, immunology, [ genetics, ] medicine, pharmacology, virology, chemistry, scientific research of vaccines, [ antibiotics, ] immunological products for human and veterinary uses; research and development for novel products for the developing world; technical consultancy relating to scientific research in the scientific, medical and veterinary domain; scientific research and development and establishment of scientific and industrial research in particular for the preparation of cells, cell lines, proteins, viruses, human and animal materials; development of vaccines; [ development of medical diagnosis techniques, therapy and test methods; ] [ medical and scientific research in the field of diagnostic and prognostic analysis of human, animal, and cellular diseases; medical and scientific research in the field of diagnostic and prognostic analysis with the help of cell lines, human and animal material, microorganisms, molecules; ] chemical, medical, pharmaceutical and bacteriological scientific researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2026INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Aug 12, 2026INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 12, 2026INPCINVALIDATION PROCESSED—
Jan 29, 2026RHRDRESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED—
Jan 9, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 8, 2026RHRDRESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED—
May 9, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 9, 202571AGREGISTERED-SEC.71 ACCEPTED—
May 9, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 9, 202571AGREGISTERED-SEC.71 ACCEPTED—
May 9, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 9, 202571AGREGISTERED-SEC.71 ACCEPTED—
May 5, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 27, 2024ES71TEAS SECTION 71 RECEIVED—
Mar 24, 2024REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 18, 2023RNWLINTERNATIONAL REGISTRATION RENEWED—
Oct 15, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 21, 2021NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Apr 21, 2021C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Apr 20, 2021EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Apr 16, 2021PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Apr 14, 2021EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Mar 30, 2021LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Mar 29, 2021PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Jan 29, 2021EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jan 7, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 7, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 7, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jan 7, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 7, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 7, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 18, 2020RHRDRESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED—
Jul 29, 2020PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Jul 28, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 8, 2020ES75TEAS SECTION 71 & 15 RECEIVED—
Mar 24, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 26, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 6, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 10, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 21, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 6, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 6, 2015FIMPFINAL DISPOSITION PROCESSED—
Jun 24, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 3, 2015OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 24, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 18, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 18, 2015OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 6, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 6, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 3, 2015GPNXNOTIFICATION PROCESSED BY IB—
Dec 17, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 17, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 17, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 4, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 3, 2014ALIEASSIGNED TO LIE—
Nov 27, 2014ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 14, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 24, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 24, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 24, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 13, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 10, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 16, 2013RFNTREFUSAL PROCESSED BY IB—
Oct 29, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 29, 2013RFRRREFUSAL PROCESSED BY MPU—
Oct 25, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 24, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 23, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2013DOCKASSIGNED TO EXAMINER—
Oct 21, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 18, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance